Virtual screening: are we there yet?


The cost of pharmaceutical development has increased dramatically in recent years, and many assorted approaches have been developed to decrease both the time and costs associated with bringing a drug to the market. Among these methods is the use of in silico screening of compound databases for potential new lead compounds, commonly referred to as virtual… (More)

Cite this paper

@article{Jalaie2006VirtualSA, title={Virtual screening: are we there yet?}, author={Mehran Jalaie and Veerabahu Shanmugasundaram}, journal={Mini reviews in medicinal chemistry}, year={2006}, volume={6 10}, pages={1159-67} }